banner

Posts tagged as: Axesstel stock quote back to homepage

Axesstel Revenue Dips in Third Quarter as Net Profit Increases Axesstel Revenue Dips in Third Quarter as Net Profit Increases(0)

Axesstel Inc. (OTCQB: AXST) Tuesday reported its earnings for the third quarter and nine months ended September 30.  Revenue for the quarter totaled $16.3 million; down from $17.1 million in the same quarter of 2011 for the provider of fixed wireless voice and broadband access solutions.  Net income significantly increased from $1.3 million, or 5 cents per diluted share, in Q3 2011 to $2.1 million, or 8 cents per diluted share, in the most recent quarter, due Read More



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.